Motion sickness susceptibility and visually induced motion sickness as diagnostic signs in Parkinson's disease

dc.contributor.authorPetel, Arthur
dc.contributor.authorJacob, Deborah Cecelia Rose
dc.contributor.authorAubonnet, Romain
dc.contributor.authorFrismand, Solène
dc.contributor.authorPetersen, Hannes
dc.contributor.authorGargiulo, Paolo
dc.contributor.authorPerrin, Philippe
dc.contributor.departmentFaculty of Medicine
dc.date.accessioned2025-11-20T09:10:09Z
dc.date.available2025-11-20T09:10:09Z
dc.date.issued2022-12-16
dc.descriptionFunding Information: A financial support was received from the Métropole du Grand Nancy, Grand Est region, northeastern France. This research was also funded by the Association France Parkinson, an association promoting research and assisting patients. Publisher Copyright: © 2022 PAGEPress Publications. All rights reserved.en
dc.description.abstractPostural instability and loss of vestibular and somatosensory acuity are among the signs encountered in Parkinson's disease (PD). Visual dependency is described in PD. These modifications of sensory input hierarchy are predictors of motion sickness (MS). The aim of this study was to assess MS susceptibility and the effects of real induced MS in posture. Sixty-three PD patients, whose medication levels (levodopa) reflected the severity of the pathology were evaluated, and 27 healthy controls, filled a MS questionnaire; 11 PD patients and 41 healthy controls were assessed by posturography using virtual reality. The levels of levodopa predicted visual MS (p=0.01), but not real induced MS susceptibility. PD patients did not experience postural instability in virtual reality, contrary to healthy controls. Since PD patients do not seem to feel vestibular stimulated MS, they may not rely on vestibular and somatosensory inputs during the stimulation. However, they feel visually induced MS more with higher levels of levodopa. Levodopa amount can increase visual dependency for postural control. The strongest MS predictors must be studied in PD to better understand the effect of visual stimulation and its absence in vestibular stimulation.en
dc.description.versionPeer revieweden
dc.format.extent840576
dc.format.extent
dc.identifier.citationPetel, A, Jacob, D C R, Aubonnet, R, Frismand, S, Petersen, H, Gargiulo, P & Perrin, P 2022, 'Motion sickness susceptibility and visually induced motion sickness as diagnostic signs in Parkinson's disease', European Journal of Translational Myology, vol. 32, no. 4, 10884. https://doi.org/10.4081/ejtm.2022.10884en
dc.identifier.doi10.4081/ejtm.2022.10884
dc.identifier.issn2037-7452
dc.identifier.other93842871
dc.identifier.other5b87fc83-42b5-4446-8f78-0a60f8b8636e
dc.identifier.other85144867717
dc.identifier.urihttps://hdl.handle.net/20.500.11815/7114
dc.language.isoen
dc.relation.ispartofseriesEuropean Journal of Translational Myology; 32(4)en
dc.relation.urlhttps://www.scopus.com/pages/publications/85144867717en
dc.rightsinfo:eu-repo/semantics/openAccessen
dc.subjectmotion sickness, motion sickness susceptibilityen
dc.subjectParkinson's diseaseen
dc.subjectvisual dependencyen
dc.subjectOrthopedics and Sports Medicineen
dc.subjectMolecular Biologyen
dc.subjectNeurology (clinical)en
dc.subjectCell Biologyen
dc.titleMotion sickness susceptibility and visually induced motion sickness as diagnostic signs in Parkinson's diseaseen
dc.type/dk/atira/pure/researchoutput/researchoutputtypes/contributiontojournal/articleen

Skrár

Original bundle

Niðurstöður 1 - 1 af 1
Nafn:
Ejtm_10884_OA_Gargiulo_EralyAccess_32.4_Dec16.pdf
Stærð:
820.88 KB
Snið:
Adobe Portable Document Format

Undirflokkur